Patients with a history of any malignancy are ineligible
Prior malignancy other than acute leukemia is allowed, provided it is in remission and there is no plan to treat the malignancy at the time of registration
Prior malignancy
History of prior malignancy, except (Criteria a through f):
History of another malignancy except for:
T-cell malignancy
Have a history of another primary malignancy, with the exception of:
MALIGNANCY CRITERIA:
History of malignancy other than their lymphoma with the exception of:
Immunosuppression, not related to prior treatment for malignancy.
Has a history of another malignancy.
Has a malignancy:
Presence of malignancy.
Resistant malignancy
History of a non-lymphoid malignancy except for protocol allowed exceptions
Any malignancy
Patients with any other prior malignancy are not allowed except for the following:
History of malignancy;
History of another primary malignancy
History of concurrent malignancy requiring active therapy or prior history of another malignancy within 5 years.
Prior chemotherapy for any malignancy
History of prior malignancy
History of prior malignancy, with the exception of the following:
Patients who have a history of any hematopoietic malignancy
History of prior malignancy except:
Prior malignancy except for any of the following:
Prior treatment for lymphoid malignancy:
Prior malignancy.
History of any other malignancy
History of another primary malignancy
Patients with a history of any other malignancy will not be eligible
another primary malignancy
History of prior malignancy for which patient is receiving other specific treatment for their cancer
Another primary malignancy
History of other malignancy (not including the underlying malignancy that was the indication for transplant)
History of other primary malignancy (including myeloid malignancy, e.g., myelodysplastic syndrome), unless
Prior history of metastatic malignancy
Actively being treated for other malignancy; if there is a history of prior malignancy, patient must not be receiving other specific treatment for their cancer
Have borderline malignancy
Patients must have pathologically-confirmed malignancy
Time since last therapy for treatment of underlying malignancy:
E 08. Prior malignancy.
Any history of another metastatic malignancy
Subjects with a history of recent (within 28 days) systemic therapy for their underlying malignancy
Prior history of other malignancy except:
Confirmed malignancy.
Prior treatment of any kind for this malignancy
History of another malignancy, some exceptions may apply.
No history of any hematopoietic malignancy
Malignancy OTHER than the BRAF mutant malignancy under study.
History of any hematopoietic malignancy
Patients may have a history of other prior malignancy
Metastatic malignancy of any kind
Metastatic malignancy of any kind
Have a diagnosed malignancy
Concurrent malignancy or metastatic malignancy of any kind
Metastatic malignancy of any kind
Other current malignancy or metastatic malignancy of any kind
Concurrent malignancy or metastatic malignancy of any kind
Women with a history of a prior malignancy
Have a second primary malignancy or any history in any time frame of a prior malignancy.
Patients may have had a prior malignancy
Other malignancy with life expectancy < 1 year due to the other malignancy
